For the patients who progress to MASH, the activity of THR-β in the liver decreases in parallel with the increase of steatosis and THR-β becomes less sensitive to thyroid hormones [55]. The gene discussed is THRB; the disease is metabolic dysfunction-associated steatohepatitis.